Transvaginal Ultrasound for Endometriosis: Learning From a Decade of Diagnostic Challenges Through a Retrospective Observational Cohort Study
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026
DOI: 10.1111/ajo.70183 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2026. Verfasst von Candice Dry und 8 weiteren Autor:innen. Beteiligte Einrichtung: King Edward Memorial Hospital, Women and Newborn Health Service, Perth, Australia. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endometriosis is a chronic, inflammatory condition associated with pelvic pain, subfertility, and reduced quality of life. Advances in enhanced transvaginal ultrasound (eTVUS), including systematic compartment‐based scanning protocols and improved operator training, have increased diagnostic accuracy, particularly for deep endometriosis.
Aims
To evaluate and critically reflect on the diagnostic performance of eTVUS during its implementation prior to the adoption of standardised scanning protocols. Using the #ENZIAN classification system, the diagnostic performance of eTVUS was assessed by comparing ultrasound findings with laparoscopic visualisation as the reference standard.
Methods
A retrospective observational study of patients with suspected endometriosis who underwent preoperative eTVUS and subsequent laparoscopy between January 2015 and January 2024 at a single tertiary hospital. Ultrasound and surgical findings were mapped to #ENZIAN compartments and grades. Agreement and diagnostic metrics were calculated using laparoscopy as the reference standard.
Results
Among 221 patients with paired ultrasound and laparoscopy, adnexal endometriomas were detected with a sensitivity of 81.4% and specificity of 84.1%. Tubo‐ovarian complex disease demonstrated a sensitivity of 72.9% and specificity of 68.8%. Sensitivity for deep endometriosis was lower, with specificity for detection depending on anatomical location varying from 83%–95%. Bladder involvement had a PPV of 83.3% and NPV of 94.8%; ureteric disease had a PPV of 0% and NPV of ~100%. Peritoneal disease was rarely identified. Conclusion eTVUS demonstrated high diagnostic accuracy for ovarian endometriomas, moderate performance for bowel involvement, and low sensitivity for peritoneal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King Edward Memorial Hospital, Women and Newborn Health Service, Perth, Australia.
- Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Australia.
ORCID-Profile: Candice Dry, Charlotte Moss, Elizabeth Nathan, Michelle K Pedretti, Glen Lo, Phillipa Robertson, Bernadette Mcelhinney, Emma R Allanson, Jan E Dickinson
Zitieren
APA
Dry, C., Moss, C., Nathan, E., Pedretti, M. K., Lo, G., Robertson, P., Mcelhinney, B., Allanson, E. R., & Dickinson, J. E. (2026). Transvaginal Ultrasound for Endometriosis: Learning From a Decade of Diagnostic Challenges Through a Retrospective Observational Cohort Study. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.70183
Vancouver
Dry C, Moss C, Nathan E, Pedretti MK, Lo G, Robertson P, et al. Transvaginal Ultrasound for Endometriosis: Learning From a Decade of Diagnostic Challenges Through a Retrospective Observational Cohort Study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026. doi:10.1111/ajo.70183
BibTeX
@article{Dry2026,
author = {Dry, Candice and Moss, Charlotte and Nathan, Elizabeth and Pedretti, Michelle K and Lo, Glen and Robertson, Phillipa and Mcelhinney, Bernadette and Allanson, Emma R and Dickinson, Jan E},
title = {Transvaginal Ultrasound for Endometriosis: Learning From a Decade of Diagnostic Challenges Through a Retrospective Observational Cohort Study},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2026},
doi = {10.1111/ajo.70183}
}
EUVIMED